As a kind of important organic acid, lactic acid is widely used in such industries as food, beverage, brewing, fragrance & flavor, medicine, leather, tobacco and chemical engineering. With the expanding application fields of lactic acid and its derivatives and the increasing consumption, demand for lactic acid also keeps increasing in China. In particular, the fast-growing beer uses lactic acid as the pH modulator. Moreover, the demand for lactic acid continues to increase in food and beverage industry.

The global lactic acid is mainly produced in the U.S., West Europe, Japan, China, etc. The fermentation method is adopted in most manufacturers. The production capacity of lactic acid is concentrated in North America, Asia and Europe. Lactic acid is widely used in many fields. In recent years, with the extremely insufficient resources and more concerns for environmental protection, the degradable polylactic acid (PLA) made from lactic acid is more widely applied.

In Chinese lactic acid industry, only 10 enterprises, such as Henan Jindan Lacitc Acid Technology Co., Ltd. and COFCO Biochemical (Anhui) Co., Ltd. can reach annual production capacity of tens of thousands of tons. Most enterprises are small-sized with annual production capacity of hundreds to thousands of tons. Many enterprises in China issued the proposed projects or expansion plans. It is expected that the annual production capacity and output volume will rapidly increase.

A sound industry chain system is formed in Chinese lactic acid industry. In terms of the constitution of upstream and downstream industries, lactic acid manufacturing industry is the extension of raw material industry, which partly realizes the development from raw materials to high-end industry chain.

In China, the major upstream raw material of lactic acid is corn starch, and the downstream includes food and beverage, medicine, chemical engineering, cosmetics and electronics industry. With the largest consumption of lactic acid, the food and beverages enjoys the annual growth rate of above 10%. The application in other industries includes leather manufacture, micro electronics, electroplating and PLA production. The output volume of China’s lactic acid exceeded more than 180,000 tons in 2015.

China’s PLA production capacity is gradually increasing. Major manufacturers include Zhejiang Hisun Biomaterials Co., Ltd., Nantong Jiuding Biological Engineering Co., Ltd., etc. It is predicted that the consumption of lactic acid for PLA production will increase in the next few years. The global production capacity of PLA is expected to increase from 200,000 tons in 2012 to 800,000 tons in 2020. However, it is estimated that the production capacity in Asia will reach 400,000 tons, accounting for nearly half of the global. Many Asian countries issue policies to support the development of various bio-based materials. In addition, Asia possesses a large number of agricultural raw materials, which will promote the development of PLA. However, there is still less demand for PLA in Asia, which indicates that most of its new production capacity will be exported.

Moreover, it is expected that the increase of downstream demand for polylactic acid will promote that of the lactic acid market in the future. The demand from food and beverage industry will also promote the increase of lactic acid. There will be a sharp increase of demand for lactic acid in food and beverage market of China and other emerging countries. Lactic acid will continue to serve as an additive in food and beverage industry and the raw material of PLA.

Through this report, the readers shall acquire the following information:

– Supply and Demand Status of Global Lactic Acid and Polylactic Acid Industry

– Influencing Factors on Development of Lactic Acid and Polylactic Acid Industry in China

– Supply and Demand of Global Lactic Acid and Polylactic Acid Industry

– Import and Export of Lactic Acid and Polylactic Acid Industry in China

– Market Competition of Lactic Acid and Polylactic Acid Industry in China

– Major Lactic Acid and Polylactic Acid Manufacturers in Chinese market

– Forecast on Development of Lactic Acid and Polylactic Acid Industry in China

The Following Enterprises and People Are Recommended to Purchase This Report:

– Lactic Acid and Polylactic Acid Manufacturers

– Downstream Subscribers of Lactic Acid and Polylactic Acid

– Investors/Research Institutes Concerned About Lactic Acid and Polylactic Acid Industry

Table of Contents

1 Basic Concepts of Lactic Acid and Polylactic Acid

1.1 Definition and Classification of Lactic Acid

1.1.1 Definition

1.1.2 Classification

1.1.3 Application Fields of Lactic Acid

1.2 Definition and Classification of Polylactic Acid

1.2.1 Definition

1.2.2 Classification

1.2.3 Application Fields of Polylactic Acid

2 Analysis of Global Lactic Acid and Polylactic Acid Industry, 2011-2015

2.1 Industry Overview

2.1.1 Production Status

2.1.2 Market Demand

2.2 Global Key Lactic Acid and Polylactic Acid Manufacturers

2.2.1 NatureWorks LLC

2.2.2 CORBION

2.2.3 Galactic

3 Development Environment of Lactic Acid and Polylactic Acid Industry in China, 2011-2016

3.1 Economic Environment

3.1.1 China Economy

3.1.2 Global Economy

3.2 Industry Policies

3.2.1 Policies on Lactic Acid Industry

3.2.2 Policies on Polylactic Acid Industry

4 Operation Status of Lactic Acid and Polylactic Acid Industry in China, 2011-2015

4.1 Supply of Lactic Acid

4.1.1 Production Capacity

4.1.2 Output Volume

4.2 Demand for Lactic Acid

4.2.1 Overall Demand

4.2.2 Demand in Niche Markets

4.3 Supply and Demand of Polylactic Acid

4.3.1 Supply

4.3.2 Demand

5 Import and Export of Lactic Acid and Polylactic Acid in China, 2011-2015

5.1 Lactic Acid

5.1.1 Export

5.1.2 Import

5.2 Polylactic Acid

5.2.1 Import

5.2.2 Export

6 Major Lactic Acid and Polylactic Acid Manufacturers in China, 2015-2016

6.1 Henan Jindan Lacitc Acid Technology Co., Ltd.

6.1.1 Enterprise Profile

6.1.2 Operation Status

6.2 Ningxia Hypow Bio-technology Co., Ltd.

6.3 COFCO Biochemical (Anhui) Co., Ltd.

6.4 Yancheng Haijianuo Biological Engineering Co., Ltd.

6.5 Chongqing Bofei Biochemical Products Co., Ltd.

6.6 Xiaogan Kaifeng Bioengineering Co., Ltd.

6.7 Musashino Chemical (China) Co., Ltd.

6.8 Shanxi Leda Biochemical Co., Ltd.

6.9 Hebei Xinhua Co., Ltd.

6.10 Zhejiang Hisun Biomaterials Co., Ltd.

6.11 Nantong Jiuding Bio-Engineering Co., Ltd.

7 Prospects of Lactic Acid and Polylactic Acid Industry in China, 2016-2020

7.1 Factors Influencing Development

7.1.1 Economic Situation

7.1.2 Policy Environment

7.1.3 Major Driving Factors

7.2 Forecast on Supply

7.2.1 Forecast on Production Capacity

7.2.2 Forecast on Output Volume

7.3 Forecast on Demand

7.3.1 Overall Demand

7. 3.2 Demand in Niche Markets

7.4 Recommendations on Development and Investment

7.4.1 Lactic Acid Industry

7.4.2 Polylactic Acid Industry

Selected Charts

Chart Global Output Volume of Lactic Acid, 2009-2015

Chart Global Key Lactic Acid and Polylactic Acid Manufacturers

Chart Output Volume of Lactic Acid in China, 2011-2015

Chart Major Lactic Acid Manufacturers and Production Capacity in China, 2015

Chart Demand for Lactic Acid in China, 2011-2015

Chart Market Size of Lactic Acid Industry in China, 2011- 2015

Chart Output Volume of Polylactic Acid in China, 2011-2015

Chart Market Size of Polylactic Acid in China, 2011-2015

Chart Export Status of Lactic Acid, Salt and Ester in China, 2011-2015

Chart Major Export Destinations of China’s Lactic Acid, Lactate and Ester, 2015

Chart Import of Lactic Acid, Salt and Ester in China, 2011-2015

Chart Major Import Sources of China’s Lactic Acid, Lactate and Ester, 2015

Chart Import of Polylactic Acid in China, 2009-2015

Chart Major Import Sources of Polylactic Acid in China, 2015

Chart Output Volume of Lactic Acid in Henan Jindan Lactic Acid Technology Co., Ltd., 2011-2015

Chart Output Volume of Polylactic Acid in Zhejiang Hisun Biomaterials Co., Ltd., 2011-2015

Chart Forecast on Output Volume of Lactic Acid in China, 2016-2020

Chart Forecast on Output Volume of Polylactic Acid in China, 2016-2020

Chart Price Trend of Lactic Acid in China, 2009-2015

Chart Forecast on Market Size of Lactic Acid in China, 2016-2020

The post Research Report on Lactic Acid and Polylactic Acid (PLA) Industry in China, 2011-2020 first appeared on CRI Report.

Chronic kidney disease (CKD), namely chronic renal insufficiency or chronic renal failure, refers to chronic kidney structure and function disorder caused by various factors. According to GFR (Glomerular filtration rate) index, chronic kidney disease is divided into five stages. Once the CKD patients enter the fifth stage, namely end-stage renal disease (ESRD) commonly known as uremia, and the renal replacement therapy must be conducted.

Hemodialysis (HD) is one of the renal replacement therapy ways to treat acute or chronic renal failure patients. Presently, there are more than 2 million end-stage renal disease (ESRD) patients all over the world who choose the dialysis therapy, and about 90% of them receive hemodialysis. Because of the high hemodialysis expenses, the dialysis patients mainly concentrate in developed countries. ESRD patients on dialysis account for 10%-20% in developing countries, which is far lower than the 80% in developed countries. The population of dialysis patients is relatively small but fast-growing. In recent years, the annual growth rate of dialysis patients reached over 10% in China, India and Brazil, which was much higher compared to 3%-5% in developed countries.

With the increasing dialysis patients, the number of the global dialysis centers is correspondingly growing, of which the growth rate is consistent with that of dialysis patients. In 2015, the global dialysis centers were estimated to reach 38,000. On average, every dialysis center provided services to 70-80 patients. Based on the relatively high dialysis rate and the slow increase of dialysis patients, it is predicted that the new hemodialysis centers will be constructed in emerging markets of Asia-Pacific regions especially China. Presently, there are a large number of unsatisfied requirements, which will be the significant points of the future dialysis market.

Up to the end of 2015, China had the population of more than 1.37 billion, and ESRD patients surpassed 2 million. Unable to afford it, only a small proportion of end-stage renal disease patients can receive the dialysis therapy. There were 300,000 dialysis patients in China by the end of 2015. The overall dialysis treatment rate was estimated to reach 14%-15% in China, which was lower than the average global level of 38%-40%. It was far lower than the above 90% treatment rate in developed countries. Therefore, there were large development potentials in Chinese dialysis market.

With the improvement of Chinese medical care as well as the increasing income and payment ability of hemodialysis patients, the hemodialysis industry will develop rapidly in the future. Hemodialysis services mainly consist of dialyzers, dialysis consumables, dialysis drugs and labor services. Hemodialysis instruments include dialysis machines, dialyzers and dialysis pipelines. Dialyzers are core consumables with high technical barriers, which accounts for the largest market share. The market size in China exceeded CNY 5 billion while the domestic market share was approximately 30% in 2015. The market size of China’s dialysis machines reached about CNY 3 billion in 2015, and the foreign capital brands accounted for 80% of the market share. The hemodialysis powder and fluid are important solvents in the process of hemodialysis. In spite of relatively low technical barriers, domestic enterprises account for over 90% of the market share thanks to the high transport cost (The reasonable transportation radius is no larger than 800 km) and policy barriers. In addition, the market competition is not fierce. Conventional hemodialysis medicines include EPO and heparin which are in general domestically produced. Service costs include costs of bed and health care labors.

Presently, the average hemodialysis expense is about 400-500 CNY for each treatment in China. The gross profit rate of hemodialysis business can universally reach 30-40% or higher. Charges in public hospitals are generally higher than those of private hospitals, of which the gross profits can reach above 50%. According to CRI, there were about 4,000 hemodialysis centers in China up to the end of 2015.

In 2015, the hemodialysis market size exceeded CNY 20 billion with an increase of more than 15% in recent years. The global ESRD patients receiving hemodialysis treatment are estimated to reach 4 million, and those in China will surpass 600,000 accounting for 15%. It is predicted that the overall market size of hemodialysis industry will increase to over CNY 50 billion by 2020.

Through this report, the readers shall acquire the following information:

-Factors Influencing the Development of Hemodialysis Industry in China

-Analysis of Hemodialysis Industry Chain in China

-Analysis of Supply and Demand in China’s Hemodialysis Industry

-Key Enterprises in China’s Hemodialysis Industry

-Market Competition Status in China’s Hemodialysis Industry

-Driving Factors for Development of China’s Hemodialysis Market

-Forecast on Development of China’s Hemodialysis Market

The Following Enterprises and People Are Recommended to Purchase This Report:

-Medical Institutions

-Manufacturers of Medical Equipment and Drugs

-Investors and Research Institutions Concerned about Hemodialysis Industry

Table of Contents

1 Related Concepts of Hemodialysis Industry

1.1 Definition

1.2 Hemodialysis Equipment

1.2.1 Hemodialysis Machine

1.2.2 Water Treatment System

1.2.3 Dialyzer

1.3 Hemodialysis Drugs

1.3.1 Hemodialysis Fluid

1.3.2 Antianemia Drugs

1.3.3 Anticoagulant

1.4 Hemodialysis Services

2 Analysis and Forecast of Global Hemodialysis Market

2.1 Dialysis Group

2.2 Coverage Rate of Hemodialysis

2.3 Hemodialysis Equipment Market

2.4 Hemodialysis Service Market

3 Development Environment of Hemodialysis Industry in China, 2011-2020

3.1 Economic Environment

3.1.1 Macro Economy

3.1.2 Resident Income

3.1.3 Medical Industry

3.2 Policy Environment

3.2.1 Industry Policies

3.2.2 Medicare Policies

4 Operation Status of Hemodialysis Industry in China, 2011-2015

4.1 Analysis on Demand

4.1.1 Demand Volume of ESRD Patients

4.1.2 Actual Number of ESRD Patients Receiving Hemodialysis

4.2 Market Size of Hemodialysis Equipment in China, 2011-2015

4.2.1 Market Size of Dialyzers

4.2.2 Market Size of Hemodialysis Machines

4.3 Market Size of Hemodialysis Drugs and Services

4.3.1 Analysis on Costs of Drugs and Services

4.3.2 Market Size of Hemodialysis Drugs

5 Competition Status of Hemodialysis Industry in China, 2011-2016

5.1 Barriers to Entry

5.1.1 Policy Barriers

5.1.2 Capital Barriers

5.1.3 Technical Barriers

5.2 Competition Structure of the Industry

5.2.1 Upstream Suppliers

5.2.2 Downstream Customers

5.2.3 Competition among Enterprises inner the Industry

5.2.4 New Entrants

5.2.5 Substitutes

6 Analysis on Import and Export of Hemodialysis Equipment and Drugs in China, 2011-2015

6.1 Analysis of Import

6.1.1 Import of Dialyzers

6.1.2 Import of Dialysis Tubing

6.1.3 Import of Hemodialysis Fluid

6.2 Analysis of Export

6.2.1 Export of Dialyzers

6.2.2 Export of Dialysis Pipelines

6.2.3 Export of Hemodialysis Fluid

7 Key Enterprises in Hemodialysis industry, 2011-2016

7.1 Fresenius Medical Care

7.1.1 Enterprise Profile

7.1.2 Analysis of Operation Status

7.2 NIPRO Medical Corporation

7.2.1 Enterprise Profile

7.2.2 Analysis of Operation Status

7.3 Baxter International Inc.

7.3.1 Enterprise Profile

7.3.2 Analysis of Operation Status

7.4 Asahi Kasei Medical Co., Ltd.

7.4.1 Enterprise Profile

7.4.2 Analysis of Operation Status

7.5 Shandong Weigao Group Medical Polymer Co., Ltd.

7. 5.1 Enterprise Profile

7.5.2 Analysis of Operation Status

7.6 SWS Hemodialysis Care Co., Ltd.

7.7 Guangdong Biolight Meditech Co., Ltd.

7.8 Sichuan Kelun Pharamceutical Co., Ltd.

7.9 Jihua Medical Apparatus & Instruments Co., Ltd. Guangzhou

7.10 Bain Medical Equipment (Guangzhou) Co., Ltd.

7.11 Zhuhai Hokai Medical Instruments Co., Ltd.

8 Prospect of Hemodialysis Industry in China, 2016-2020

8.1 Factors Influencing Development

8.1.1 Macro Economy

8.1.2 Government Policies

8.1.3 Major Driving Forces

8.2 Forecast on Supply

8.2.1 Forecast on Supply of Hemodialysis Equipment

8.2.2 Forecast on Supply of Hemodialysis Drugs and Services

8.3 Prediction on Demand

8.3.1 Prediction on Market Size

8.3.2 Forecast on Demand in Niche Markets

8.4 Recommendations on Development and Investment

8.4.1 Investment Opportunities

8.4.2 Development Proposals

Selected Charts

Chart Estimation of ESRD Dialysis Treatment Rate in Different Countries

Chart Global Market Pattern of Dialysis Equipment, 2015

Chart Total Medical Expenses in China, 2006-2015

Chart Market Size of Hemodialysis Services in China, 2011-2015

Chart Market Size of Hemodialyzers in China, 2011-2015

Chart Market Size of Hemodialysis Drugs in China, 2011-2015

Chart Import Status of Renal Dialysis Equipment in China, 2011-2015

Chart Export Status of Renal Dialysis Equipment in China, 2011-2015

Chart Operation Status of Fresenius Medical Care, 2011-2015

Chart Operation Status of NIPRO Medical Corporation, 2011-2015

Chart Operation Status of Shandong Weigao Group Medical Polymer Co., Ltd., 2011-2015

Chart Operation Status of Guangdong Biolight Meditech Co., Ltd., 2011-2015

Chart Output Volume of Hemodialysis Related Products in Guangdong Biolight Meditech Co., Ltd., 2013-2015

Chart Prediction on Market Size of Hemodialysis Services in China, 2016-2020

Chart Prediction on Market Size of Hemodialysis Drugs in China, 2016-2020

The post Research Report on Hemodialysis Industry in China, 2011-2020 first appeared on CRI Report.

In China, city commercial bank is basically the same as normal commercial bank, engaging in financial business permitted by People’s Bank of China including deposit and loan, settlement, remittance, and intermediate business.

The biggest difference between city commercial bank and normal commercial bank is the dissimilar service field. City Commercial Bank is reformed from the former city credit union and foundation. As a regional financial institution, its service region is much smaller than other commercial banks such as Industrial and Commercial Bank of China，Agricultural Bank of China, Bank of China, China Construction Bank.

By the end of 2015, there were 132 city commercial banks in China. Ranked by the asset scale, Bank of Beijing, Bank of Shanghai, Bank of Jiangsu, bank of Ningbo and Bank of Nanjing were in the front.

By the end of 2015, total assets of city commercial banks reached CNY 22.68 trillion, with a 25.4% growth compared to the early 2015, accounting for more than 11% of total assets in the banking industry.

City commercial banks keep stable growing which supports China’s steady economic growth. On the one hand, they actively take all kinds of important strategic opportunities to seek cooperation with big clients; on the other hand, they continually strengthen to support for agriculture, small enterprises, especially to support small enterprises, which can acquire more loans from CCBs.

By the end of 2015, loan balance of all china commercial banks offered to small enterprise (including small enterprise loan, individual business loan and small business owner loan) totaled CNY 17.67 trillion, with an increase of 10.91% compared to the beginning of 2015. Among them, loan from city commercial banks to small enterprises accounted for 21.05%, which was almost the same as that from joint-stock banks, slightly lower than that from state-owned commercial Banks. In 2015, loans from city commercial banks to small enterprise increased by 16.02 % year on year, which is far higher than the overall level of that from commercial banks, large state-owned banks as well as joint-stock banks.

To supplement capital as soon as possible, China’s city commercial banks focus on the Hong Kong stock market in succession. Bank of Qingdao, Bank of Jinzhou bank, Bank of Zhengzhou were listed in HKex to get financing.

On Dec. 3, 2015, Bank of Qingdao officially was listed in HKex. The issued scale of Bank of Qingdao added up to 947 million, with the price of HKD 4.75 per share. It raised nearly HKD 4.5 billion.

On Dec. 8, 2015, Bank of Jinzhou was officially listed in HKex, which sold 1.32 billion shares in total. The final price was HKD 4.66 per share and it raised HKD 6 billion in total.

On Dec. 23 2015, Bank of Zhengzhou was officially listed in HKex, which sold 1.32 billion shares in total. The final price was HKD 3.85 per share and it raised HKD 5 billion.

In terms of comprehensive operation, most city commercial banks operate with fund companies, financial leasing companies based according to their own status. Among them, large city commercial banks progressed fast.

In terms of differential operation, city commercial banks concentrate manpower and material resources through cultivating the core business to develop their own advantages because of the big gap between large state-owned banks and joint-equity banks in manpower and material resources.

Through This Report, readers can get more:

-Definition and Classification of City Commercial Bank

-Parameter and Hypothesis

-Competition of China City Commercial Bank Industry

-Top 10 City Commercial Banks in China

-Development Opportunity of China City Commercial Bank Industry

-Major Forces Driving the Development of China City Commercial Bank Industry

-Risk Facing the Development of China City Commercial Bank Industry

-Analysis on Major Operation Cost of City Commercial Banks in China

Table of Contents

1 Research Methodology of City Commercial Bank Industry

1.1 Definition and Classification of City Commercial Bank

1.2 Parameter and Hypothesis

1.3 Reliability Validation

1.4 CRI Profile

2 Operation of China City Commercial Bank Industry 2011-2020

2.1 Development Environment of City Commercial Bank Industry

2.1.1 Economy Environment

2.1.2 Policy Environment

2.2 Supply Condition of China City Commercial Bank Industry

2.3 Market Scale of City Commercial Banks in China

2.4 Major Client Group of City Commercial Banks in China

3 Analysis of Competition of China City Commercial Bank Industry, 2011-2020

3.1 Barriers to Entry for City Commercial Banks

3.1.1 Policy Barriers

3.1.2 Fund Barriers

3.1.3 Client Resource Barriers

3.2 Competition Structure of City Commercial Bank Industry

3.2.1 Supplier Bargaining Power

3.2.2 Client Bargaining Power

3.2.3 Internal Competition of City Commercial Bank Industry

3.2.4 Potential Entrants of City Commercial Bank Industry

3.2.5 Substitutes of City Commercial Bank

4 Analysis of Top 10 China City Commercial Banks, 2013-2015

4.1 Bank of Beijing

4.1.1 Enterprise Profile

4.1.2 Market Share of Bank of Beijing

4.1.3 Analysis on Status of Bank of Beijing in City Commercial Bank Industry

4.2 Bank of Jiangsu

4. 2.1 Enterprise Profile

4.2.2 Market Share of Bank of Jiangsu

4.2.3 Analysis on Status of Bank of Jiangsu in City Commercial Bank Industry

4.3 Bank of Shanghai

4. 3.1 Enterprise Profile

4.3.2 Market Share of Bank of Shanghai

4.3.3 Analysis on Status of Bank of Shanghai in City Commercial Bank Industry

4.4 Bank of Ningbo

4. 4.1 Enterprise Profile

4.4.2 Market Share of Bank of Ningbo

4.4.3 Analysis on Status of Bank of Ningbo in City Commercial Bank Industry

4.5 Bank of Nanjing

4. 5.1 Enterprise Profile

4. 5.2 Market Share of Bank of Nanjing

4. 5.3 Analysis on status of Nanjing Bank in City Commercial Bank Industry

4.6 Huishang Bank

4.7 Shengjing Bank

4.8 Bank of Tianjin

4.9 Bank of Hangzhou

4.10 Xiamen International Bank

4.11 Analysis on Advantageous Enterprises

5 Analysis on Deposit and Loan Interest Rate of China City Commercial Bank Industry, 2013-2015

5.1 Analysis on Deposit Interest Rate,  2013-2015

5.1.1 Tendency

5.1.2 Analysis on Undulation Factors

5.2 Analysis on Loan Interest Rate ,2013-2015

5. 2.1 Tendency

5.2.2 Analysis on Undulation Factors

6 Predictions on the Development of China City Commercial Bank Industry, 2016-2020

6.1 Factors Influencing Development

6.1.1 Major Driving Forces and Market Opportunities

6.1.2 Threats or Challenges

6.2 Prediction on Industry Supply

6.3 Prediction on Market Demand

Selected Charts

Chart Total Assets (CNY 1 billion) of China City Commercial Bank Industry, 2011-2015

Chart Total Assets (CNY 1 billion) of China Large Commercial Banks, 2011-2015

Chart Top 10 City Commercial Banks in China, 2013-2015

Chart Operation Revenues of Bank of China, 2013-2015

Chart Operation Revenues of Bank of Jiangsu, 2013-2015

Chart Market Share of Bank of Jiangsu in China City Commercial Banks

Chart Operation Revenues of Bank of Shanghai, 2013-2015

Chart Market Share of Bank of Shanghai in China City Commercial Banks

Chart Operation Revenues of Bank of Ningbo, 2013-2015

Chart Benchmark Interest Rate of RMB Deposit in Financial Institution, 2013-2015

Chart Benchmark Interest Rate of RMB Loan in Financial Institution, 2013-2015

Chart Total Deposits of China City Commercial Banks, 2011-2020

Chart Total Loan of China City Commercial Banks, 2011-2020

The post China City Commercial Bank (CCB) Industry Overview, 2011-2020 first appeared on CRI Report.